SNWV News Alert Sanuwave Health Inc (SNWV) 0.2300 02/15/2015
Post# of 64074
Posted On: 02/15/2015 2:36:54 PM
Sanuwave Health Inc (SNWV) 0.2300 $SNWV
OTC Daily Alert Stock Watch - SANUWAVE Health, Inc (OTC: SNWV)
WorldStockWire - Mon Dec 15, 2:00AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
SANUWAVE Health Signs Memoranda of Understanding With Dasman Diabetes Institute and Kuwait Life Sciences Company
GlobeNewswire - Tue Dec 02, 7:39AM CST
Companies to Establish a Strategic Alliance and Joint Venture to Introduce the dermaPACE Device as a Preferred Treatment for Diabetic Foot Ulcers in the Gulf Cooperation Council Region
SANUWAVE Enrolls 130th Patient in Its dermaPACE Clinical Trial Treating Diabetic Foot Ulcers
GlobeNewswire - Mon Dec 01, 7:30AM CST
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has enrolled its 130 patient in the Phase III supplemental clinical trial using dermaPACE for treating diabetic foot ulcers (DFU's), which represents the number of patients the Company must enroll for the second interim analysis by the independent Data Monitoring Committee (DMC). The Company has suspended further enrollment in the study until the Data Monitoring Committee provides feedback on the 130 patients.
SANUWAVE Health's (SNWV) CEO Kevin Richardson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 1:13PM CST
SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update
GlobeNewswire - Wed Nov 12, 4:13PM CST
SANUWAVE Health, Inc. (OTCQB:SNWV) today reported financial results for the three and nine months ended September 30, 2014 and provided a business update. The Company will host a conference call on Thursday, November 13, 2014, at 10:00 a.m. Eastern Time.
SANUWAVE Health to Hold Third Quarter 2014 Financial Results Conference Call on Thursday, November 13
GlobeNewswire - Thu Nov 06, 7:42AM CST
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the third quarter ended September 30, 2014 after the markets close on November 12, 2014.
SANUWAVE Health Receives Information From the Data Monitoring Committee on the dermaPACE Clinical Trial
GlobeNewswire - Wed Sep 10, 7:30AM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the independent Data Monitoring Committee (DMC) has performed an interim analysis on the efficacy results for the first 90 patients in the Phase III supplemental clinical trial using the dermaPACE for treating diabetic foot ulcers. The DMC has recommended the Company continue enrollment of patients into the study up to the next predefined patient analysis point of 130 patients. The Company has continued to enroll patients while waiting on the 12 week efficacy analysis for the first 90 patients and expects to complete enrollment for the 130 patients by October 31, 2014.
SANUWAVE Health to Present at Upcoming Financial Conferences
GlobeNewswire - Wed Aug 27, 7:35AM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced the Company's upcoming financial conference schedule:
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Aug 19, 3:34PM CDT
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"
TM) television program will feature three companies on Fox Business nationwide on Tuesday, August 19, 2014 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg U.K. Saturday, August 23, 2014 at 12:30 a.m. GMT; on Bloomberg Europe on Sunday, August 24, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday, August 24, 2014 at 3:30 p.m. HKT.
PFIE: 2.60 (-0.06)
SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update
GlobeNewswire - Wed Aug 06, 4:15PM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today reported financial results for the three and six months ended June 30, 2014 and provided a business update. The Company will host a conference call on Thursday, August 7, 2014, at 11:00 a.m. Eastern Time.
SANUWAVE Health to Hold Second Quarter 2014 Financial Results Conference Call on Thursday, August 7
GlobeNewswire - Tue Jul 29, 4:26PM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the second quarter ended June 30, 2014 after the markets close on August 6, 2014.
SANUWAVE Health Signs Strategic Agreement With Premier Shockwave to Manage OssaTron Devices
GlobeNewswire - Tue Jul 22, 7:31AM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has signed a strategic agreement with Premier Shockwave, Inc. to manage the Company's OssaTron devices. The three year agreement with Premier Shockwave will provide SANUWAVE with an opportunity to monetize these assets, which represent the first and only extracorporeal shock wave therapy (ESWT) system approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple orthopedic conditions that have failed to respond to conservative treatment.
RedChip Issues Research Profile on SANUWAVE Health
GlobeNewswire - Mon Jun 23, 8:41AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on SANUWAVE Health, Inc. (OTCQB:SNWV), a shock wave technology company focused on the development and commercialization of patented non-invasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
OTC Daily Alert Stock Watch - SANUWAVE Health, Inc (OTC: SNWV)
WorldStockWire - Mon Dec 15, 2:00AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
SANUWAVE Health Signs Memoranda of Understanding With Dasman Diabetes Institute and Kuwait Life Sciences Company
GlobeNewswire - Tue Dec 02, 7:39AM CST
Companies to Establish a Strategic Alliance and Joint Venture to Introduce the dermaPACE Device as a Preferred Treatment for Diabetic Foot Ulcers in the Gulf Cooperation Council Region
SANUWAVE Enrolls 130th Patient in Its dermaPACE Clinical Trial Treating Diabetic Foot Ulcers
GlobeNewswire - Mon Dec 01, 7:30AM CST
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has enrolled its 130 patient in the Phase III supplemental clinical trial using dermaPACE for treating diabetic foot ulcers (DFU's), which represents the number of patients the Company must enroll for the second interim analysis by the independent Data Monitoring Committee (DMC). The Company has suspended further enrollment in the study until the Data Monitoring Committee provides feedback on the 130 patients.
SANUWAVE Health's (SNWV) CEO Kevin Richardson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 1:13PM CST
SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update
GlobeNewswire - Wed Nov 12, 4:13PM CST
SANUWAVE Health, Inc. (OTCQB:SNWV) today reported financial results for the three and nine months ended September 30, 2014 and provided a business update. The Company will host a conference call on Thursday, November 13, 2014, at 10:00 a.m. Eastern Time.
SANUWAVE Health to Hold Third Quarter 2014 Financial Results Conference Call on Thursday, November 13
GlobeNewswire - Thu Nov 06, 7:42AM CST
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the third quarter ended September 30, 2014 after the markets close on November 12, 2014.
SANUWAVE Health Receives Information From the Data Monitoring Committee on the dermaPACE Clinical Trial
GlobeNewswire - Wed Sep 10, 7:30AM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the independent Data Monitoring Committee (DMC) has performed an interim analysis on the efficacy results for the first 90 patients in the Phase III supplemental clinical trial using the dermaPACE for treating diabetic foot ulcers. The DMC has recommended the Company continue enrollment of patients into the study up to the next predefined patient analysis point of 130 patients. The Company has continued to enroll patients while waiting on the 12 week efficacy analysis for the first 90 patients and expects to complete enrollment for the 130 patients by October 31, 2014.
SANUWAVE Health to Present at Upcoming Financial Conferences
GlobeNewswire - Wed Aug 27, 7:35AM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced the Company's upcoming financial conference schedule:
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Aug 19, 3:34PM CDT
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" TM) television program will feature three companies on Fox Business nationwide on Tuesday, August 19, 2014 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg U.K. Saturday, August 23, 2014 at 12:30 a.m. GMT; on Bloomberg Europe on Sunday, August 24, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday, August 24, 2014 at 3:30 p.m. HKT. PFIE: 2.60 (-0.06)
SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update
GlobeNewswire - Wed Aug 06, 4:15PM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today reported financial results for the three and six months ended June 30, 2014 and provided a business update. The Company will host a conference call on Thursday, August 7, 2014, at 11:00 a.m. Eastern Time.
SANUWAVE Health to Hold Second Quarter 2014 Financial Results Conference Call on Thursday, August 7
GlobeNewswire - Tue Jul 29, 4:26PM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the second quarter ended June 30, 2014 after the markets close on August 6, 2014.
SANUWAVE Health Signs Strategic Agreement With Premier Shockwave to Manage OssaTron Devices
GlobeNewswire - Tue Jul 22, 7:31AM CDT
SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has signed a strategic agreement with Premier Shockwave, Inc. to manage the Company's OssaTron devices. The three year agreement with Premier Shockwave will provide SANUWAVE with an opportunity to monetize these assets, which represent the first and only extracorporeal shock wave therapy (ESWT) system approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple orthopedic conditions that have failed to respond to conservative treatment.
RedChip Issues Research Profile on SANUWAVE Health
GlobeNewswire - Mon Jun 23, 8:41AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on SANUWAVE Health, Inc. (OTCQB:SNWV), a shock wave technology company focused on the development and commercialization of patented non-invasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
(0)
(0)Scroll down for more posts ▼